Close Menu

Robert Schwartz of the University of Houston has devised a method for reprogramming human skin cells into early-stage heart cells. These cells can then be implanted and grown into fully-developed beating heart cells, reversing damage caused by heart attacks. Schwartz's method differs from those of other stem cell researchers in that it requires fewer steps and yields more cells. First, the cells are treated with a virus and are transformed into induced pluripotent stem cells.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

NPR reports the US Food and Drug Administration has approved a treatment for a genetic disorder that causes rapid aging.

Late-stage testing indicates the AstraZeneca and Oxford University SARS-CoV-2 vaccine can have up to 90 percent efficacy, the Associated Press reports.

ScienceInsider reports Nature Communications is reviewing a paper on mentorship following social media criticism arguing it is sexist.

In PLOS this week: method to account for sequencing errors in phylogenies, study of influenza A in Switzerland, and more.